A5087364666- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Thyroid Disorders and Treatments
- Cardiac electrophysiology and arrhythmias
- Thyroid Cancer Diagnosis and Treatment
- Cardiac Imaging and Diagnostics
- Hormonal Regulation and Hypertension
- Cardiac Arrhythmias and Treatments
- Cardiac Structural Anomalies and Repair
- Hormonal and reproductive studies
- Potassium and Related Disorders
- Cardiac Valve Diseases and Treatments
- Ion channel regulation and function
- Electrolyte and hormonal disorders
- Pericarditis and Cardiac Tamponade
- Thyroid and Parathyroid Surgery
- Ultrasound and Hyperthermia Applications
- Adrenal Hormones and Disorders
- IL-33, ST2, and ILC Pathways
- Pulmonary Hypertension Research and Treatments
- Cardiac pacing and defibrillation studies
- Dermatological and Skeletal Disorders
- Healthcare Facilities Design and Sustainability
- Atrial Fibrillation Management and Outcomes
Ospedale A. Perrino
2020-2024
Ospedale Santa Maria
2024
Ospedali Riuniti di Foggia
2024
Azienda Ospedaliera Santa Maria Degli Angeli
2024
Ospedale Vito Fazzi
2024
Casa Sollievo della Sofferenza
2024
University of Bari Aldo Moro
2017-2022
University of Parma
2015-2019
Istituto Nazionale di Fisica Nucleare, Sezione di Napoli
2014
Professional athletes exhibit lower left ventricular wall thicknesses, diameters and mass (in females), with less frequent training-related electrocardiogram (ECG) changes, as compared controls. We studied the association of sex structure in trained early adolescents. Two hundred six adolescent Caucasian (mean age 13.8 ± 1.6, range 11.8–16.9 years, 158 males 48 similar degree training underwent ECG echocardiographic measurements diameters, thicknesses mass, relative thickness remodelling...
Galectin-3 and ST2 are emerging biomarkers involved in myocardial fibrosis. We evaluate the relevance of a multiparametric biomarker approach based on increased serum levels NT-proBNP, galectin-3, stratifying prognosis chronic heart failure (CHF) outpatients. In 315 CHF outpatients stable clinical condition echocardiographic evaluations were performed. Routine chemistry also assessed. During 12 month follow-up, cardiovascular death, and/or (HF) occurred 64 patients. The presence higher than...
Aim: The aim of the study was to evaluate association between Gal-3 serum levels and progression renal dysfunction in chronic heart failure outpatients. Methods & results: This prospective 260 patients showed that associated with 1-year worsening function both univariate (odds ratio: 1.12; 95% CI: 1.06-1.18; p < 0.001) forward stepwise multivariate 1.09; 1.03-1.15; = 0.004) logistic regression analyses. Moreover, high at baseline were a progressive decline estimated glomerular filtration...
Some forms of early ECG repolarization QRS pattern (ERp) with J-point elevation 0.1 mV in two contiguous inferior and/or lateral leads or without ST-elevation are potentially associated a higher arrhythmic risk adults. We assessed the prevalence ERp among non-professional adolescent athletes and correlated it age, sex, ethnicity, structural electric cardiac parameters. retrospectively analyzed 414 ECGs obtained from young referred to our center 2006 2017. found 22% cases. In group, we...
Background: Thyroid disorders may have a negative impact on the prognosis of patients affected by chronic heart failure (CHF). Objective: The aim current study was to evaluate prognostic role all thyroid over long term follow-up in single centre large sample CHF outpatients. Methods: In patients, function evaluated at enrolment and during follow- up. On basis free triiodothyronine (T3), thyroxine (fT4) thyroid-stimulating hormone (TSH) serum levels, were classified into one following four...
Abstract Aims Sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) have been shown to a relevant role in the prevention of hospitalizations for heart failure and improvement life expectancy patients with diabetes outpatients chronic (CHF) reduced left ventricular ejection fraction, independently from presence type 2 mellitus (T2DM). The aim our study was evaluate real‐world population number CHF who meet enrolment criteria main randomized controlled trials (RCT) published last 5 years...
Sacubitril/valsartan plays a key role in improving left ventricular remodeling and prognosis patients with heart failure reduced ejection fraction (HFrEF). Moreover, some data support its preserving renal function. In order to better clarify the effects of sacubitril/valsartan cardiorenal syndrome, this study evaluated on resistance index (RRI).A group HFrEF was enrolled. The RRI assessed echo-color Doppler at enrollment again after least six months treatment. subgroup patients, also before...
<b><i>Background:</i></b> Hyperkalemia is one of the most frequent side effects related to renin-angiotensin-aldosterone system (RAAS) inhibition, and can influence optimization heart failure (HF) therapy. <b><i>Aim:</i></b> To evaluate occurrence hyperkalemia in a series outpatients with chronic HF its relationship RAAS inhibitor <b><i>Method:</i></b> We evaluated consecutive reduced left ventricular ejection fraction....
Hypothyroidism is a frequently observed comorbidity in patients with chronic heart failure (CHF), possibly giving rise to unfavorable outcomes.The aim of the study was evaluate impact TSH changes over time on cardiac function and prognosis outpatients CHF.Patients underwent clinical, electrocardiographic, echocardiographic evaluations at baseline after 12 months. Moreover, blood chemistry tests were performed renal function, biomarkers, fT3, fT4, levels. Based serum levels, retrospectively...
Abstract Background Over the last few years, treatment with sodium glucose cotransporter 2 inhibitors (SGLT2i) dapaglifozin and empaglifozin was shown to reduce combined risk of cardiovascular death and/or hospitalization for heart failure (HF) among patients reduced ejection fraction. Subsequent RCTs have demonstrated similar reduction in endpoint also left ventricular fraction (LVEF) &gt;40%. Nevertheless, real world data on current state implementation SGLT2i therapy HF clinical...
Abstract Background Dobutamine Stress Echo (DSE) is a test widely used in the diagnosis of ischemic heart disease. The purpose following work to describe clinical case with uncommon behaviour. Case Description: 63–year–old female dyspnoea on mild exertion, and history NSTEMI–ACS 5 years prior Coronary Angiography (CA) finding 3–vessel coronary artery disease, treated PCI + stent (DES) right (CDX), untreated disease sub–occlusion first marginal obtuse (OM1), chronic occlusion anterior...
Atrial masses are rare and more often localized in the right atrium. They usually detected incidentally, leading causes tumors, thrombi, or infective vegetations. However, normal structures artifacts ("pseudomasses") should also be considered differential diagnosis, especially after cardiac and/or aortic surgery. We present a case of an unusual left atrial image observed on transthoracic echocardiography 83-year-old woman intervention open-chest ascending aorta replacement myocardial...
Journal Article IMAGING 1 Get access European Heart Supplements, Volume 21, Issue Supplement_E, May 2019, Pages E161–E163, https://doi.org/10.1093/eurheartj/suz164 Published: 16 2019
Abstract Background Tako Tsubo syndrome (TTS) is characterized by transient alterations of ventricular kinetics (ATC) in the absence obstructive epicardial coronary artery disease. Materials 39 cases TTS that came to our observation from 2005 2019 are described, diagnosis was made on basis evidence ATC, ECG alterations, increase necrosis markers disease, excluding myocarditis. Results patients (PZ) (35 females and 4 males) diagnosed with had an average age 61 ± 13.21 years symptoms at onset...